Theralink Technologies Inc (THER)

[penny_hunter_]

Board Members Info. A little reminder of our smart board members

About the company and their pipelines "17B dollar in the next 3 years on prostate cancer!" https://www.youtube.com/watch?v=vUQtId7LLsA" rel="nofollow" target="_blank" >Interview with Jonathan Head & Andrew Kucharchuk -CEO/CFO of OncBioMune Pharmaceuticals Inc.

Dr. Robert Elliott, M.D., Ph.D.

Dr. Robert Elliott graduated from Delta State University with a B.S. in 1959. He then attended the University of Mississippi School of Medicine where he received his M.D. in 1961. He then attended LaSalle University where he received his Ph.D. in 1994, then receiving his D. Sci. (h.c.) in 2009 from Delta State University.
Dr. Elliott has completed many post graduate programs and has many appointments, awards and belongs to several honor societies. Dr. Elliott belongs to over 40 organizations, and has completed 9 exhibits. He has over 90 papers published with over 150 abstracts, is included in 3 different book chapters, published on book called Breast Cancer- Anger at the Enemy. He is also responsible for 6 patents.

http://www.breastoncology.com/dr-robert-elliott

Venerated Surgical Oncologist, Robert Lange Elliott, MD, PhD, DSc, will be Displayed in The Leading Physicians of the World

Charles L. Rice, Jr.

Mr. Rice is the President and Chief Executive Officer of Entergy New Orleans, Inc., an $800 million a year electric and gas utility and subsidiary of NYSE-listed Entergy Corporation. After his first legal private practice position in Louisiana with Jones, Walker, Waechter, Poitevent, Carrere & Denegre, L.L.P, Rice joined Entergy in the legal department in 2000, serving as senior counsel in the Entergy Services, Inc. litigation group and then as manager of labor relations litigation support in human resources.

Rice was recruited into New Orleans city government in 2002 as the city attorney and later took the critical role of chief administrative officer for the City of New Orleans, where he managed 6,000 employees and the city’s $600 million budget. In 2005, the law firm of Barrasso, Usdin, Kupperman, Freeman & Sarver, L.L.C. recruited him back to private practice, where he was named partner.

Returning to Entergy in 2009, Rice served as director of utility strategy where he was responsible for coordinating regulatory, legislative, and communications efforts to develop and execute strategies that advanced commercial objectives for the company’s regulated service areas. He then served as director of regulatory affairs for Entergy New Orleans.

Rice holds a bachelor’s degree in business administration from Howard University, a juris doctorate from Loyola University’s School of Law and master’s degree in business administration from Tulane University. After graduating from Howard University, he was commissioned as a second lieutenant in the United States Army and served as a military intelligence officer with the 101st Airborne Division (Air Assault) at Fort Campbell, KY. While in the Army, he earned the Airborne Badge, Air Assault badge and was awarded the Army Commendation and the Army Achievement medals.

He is a member of the Alabama and Louisiana State Bar Associations, the American Bar Association, the New Orleans Bar Association, and the National Bar Association.

PRESIDENT & CEO, ENTERGY NEW ORLEANS, LLC

Daniel S. Hoverman

Mr. Daniel S. Hoverman has been Managing Director of Regions Securities LLC since May 16, 2017. Mr. Hoverman served as General Counsel and a Director at UBS in New York in the Equity Capital Markets Group. Mr. Hoverman started his career with Kirkland & Ellis in New York, where he was a Corporate Attorney. He has over 15 years of experience advising on complex transactions, including public company, international, dual track and similar situations, as well as restructuring ...

https://www.bloomberg.com/research/stocks/people/person.asp?personId=321329470&privcapId=304861406

Mr. Hoverman is a Managing Director at Regions Securities, where he focuses on mergers and acquisitions advisory and equity capital markets transactions. Mr. Hoverman has extensive M&A advisory and financing experience, including buy-side and sell-side advisory for dual-track, cross-border, tax driven and special situations transactions.

Previously, Mr. Hoverman was a Director at Houlihan Lokey, where he focused on mergers and acquisitions advisory, and was actively involved with the firm’s efforts in equity capital markets. Before joining Houlihan Lokey, Mr. Hoverman was a Director with Credit Suisse Group in Hong Kong and a Director with UBS AG in New York. He began his career with Kirkland & Ellis LLP as a corporate attorney focusing on capital markets and M&A transactions.

Mr. Hoverman received a B.A. from Yale University, where he graduated cum laude with distinction in history and was a Robert C. Bates Fellow and New Prize recipient. He received a J.D. and M.B.A. from Columbia University, where he was a James Kent Scholar and a John C. Olin Fellow. Mr. Hoverman holds Series 7, 24, 63 and 79 licenses and the designation of Chartered Financial Analyst, and is an inactive member of the New York Bar.

https://www.linkedin.com/in/daniel-hoverman-3b385968/